Table 3.
Cardiorespiratory and neural responses to hyperoxic end-expiratory apnea
| Normoxic Baseline | Hyperoxic Baseline | Hyperoxic Apnea | P Value | |
|---|---|---|---|---|
| Heart rate, beats/min | 64 ± 2 | 63 ± 2 | 67 ± 5 | 0.53 |
| Systolic blood pressure, mmHg | 145 ± 4 | 146 ± 4 | 157 ± 6*† | <0.01 |
| Diastolic blood pressure, mmHg | 78 ± 2 | 79 ± 3 | 89 ± 3*† | <0.01 |
| Mean blood pressure, mmHg | 100 ± 3 | 101 ± 3 | 113 ± 4*† | <0.01 |
| Oxygen saturation (% ) | 99 ± 0 | 100 ± 0 | 0.07 | |
| , mmHg | 110 ± 5 | 444 ± 19* | <0.01 | |
| , mmHg) | 38 ± 1 | 36 ± 2* | 0.03 | |
| Respiratory rate, breaths/min | 11 ± 1 | 12 ± 1 | 0.17 | |
| Tidal volume, L/breath | 0.75 ± 0.18 | 0.80 ± 0.15 | 0.47 | |
| Minute ventilation, mL/min | 7.6 ± 1.3 | 8.8 ± 1.3* | 0.048 | |
| Burst frequency, bursts/min | 24 ± 4 | 21 ± 2 | 28 ± 5 | 0.14 |
| Burst incidence, bursts/100 heartbeats | 38 ± 6 | 33 ± 3 | 47 ± 8 | 0.12 |
| Mean burst area, AU/min | 1.3 ± 0.3 | 1.1 ± 0.2 | 1.2 ± 0.3 | 0.93 |
| AP frequency, APs/min | 155 ± 35 | 155 ± 30 | 253 ± 71 | 0.12 |
| AP incidence, APs/burst | 6 ± 1 | 8 ± 2 | 8 ± 1 | 0.18 |
| AP incidence, APs/100 heartbeats | 249 ± 61 | 258 ± 55 | 502 ± 188 | 0.28 |
| Mean cluster incidence, clusters/burst | 3.7 ± 0.5 | 3.6 ± 0.3 | 4.2 ± 0.6 | 0.57 |
| Max cluster incidence, clusters/burst | 6.4 ± 0.7 | 6.6 ± 0.6 | 7.0 ± 1.3 | 0.78 |
| Max cluster number | 13.2 ± 1.7 | 11.9 ± 0.9 | 11.2 ± 2.2 | 0.31 |
| Data duration, s | 107 ± 9 | 103 ± 9 | 32 ± 11* | 0.01 |
Data are reported as means ± SE for n = 9 subjects. AP, action potential; AU, arbitrary units; , arterial O2 saturation from pulse oximetry. Data were analyzed with a 1-way repeated-measures ANOVA. Normality was assessed with the Shapiro–Wilk test. If not normally distributed, a Friedman repeated-measures ANOVA on ranks was conducted. Pairwise comparisons were done with the Holm–Sidak method. Bold type signifies statistical significance.
P < 0.05 vs. normoxia;
P < 0.05 vs. hyperoxia.